Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

ClinicalTrials.gov ID: NCT05402371

Public ClinicalTrials.gov record NCT05402371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2B, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rencofilstat in Adult Subjects With Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as evidenced by histopathological improvements in fibrosis in adult NASH subjects with F2 or F3 fibrosis (NASH CRN system). Antifibrotic biomarker activity will be evaluated on an exploratory basis.

Study identification

NCT ID
NCT05402371
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hepion Pharmaceuticals, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2022 (Actual)
Primary completion
May 2025 (Estimated)
Completion
Sep 2025 (Estimated)
Last update posted
May 3, 2024

2022 – 2025

United States locations

U.S. sites
39
U.S. states
13
U.S. cities
36
Facility City State ZIP Site status
Medical Affiliated Research Center Huntsville Alabama 35801 —
Arizona Liver Health-Chandler Chandler Arizona 85224 —
Arizona Liver Health Peoria Arizona 85381 —
Adobe Clinical Research, LLC Tucson Arizona 85712 —
Arizona Liver Health-Tuscon Tucson Arizona 85712 —
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Arkansas Gastroenterology North Little Rock Arkansas 72117 —
National Research Institute Huntington Park California 90255 —
National Research Institute Los Angeles California 90057 —
National Research Institute Panorama City California 91402 —
National Research Institute Santa Ana California 92704 —
Synergy Healthcare, LLC Bradenton Florida 34208 —
Tampa Bay Medical Research, Inc. Clearwater Florida 33761 —
Top Medical Research, Inc. Cutler Bay Florida 33189 —
Integrity Clinical Research, LLC Doral Florida 33166 —
Evolution Clinical Trials, Inc. Hialeah Gardens Florida 33016 —
Borland Groover Clinical Research Jacksonville Florida 32256 —
Ocala GI Research Lady Lake Florida 32159 —
Accel Research Sites-Lakeland CRU Lakeland Florida 33803 —
Future Care Solutions, LLC Miami Florida 33165 —
Entrust Clinical Research Miami Florida 33176 —
United Reseach Group Miami Florida 33186 —
Omega Research Consultants, LLC Orlando Florida 32810 —
Progressive Medical Research Port Orange Florida 32127 —
Covenant Research and Clinics Sarasota Florida 34240 —
Southeast Clinical Research Center Dalton Georgia 30720 —
Gastrointestinal Specialists of Georgia, PC Marietta Georgia 30060 —
Digestive Research Alliance of Michiana, LLC South Bend Indiana 46635 —
Delta Research Partners Bastrop Louisiana 71220 —
Mid-Atlantic GI Research, LLC Greenbelt Maryland 20770 —
AIG Digestive Disease Research, LLC Florham Park New Jersey 07932 —
Pinnacle Clinical Research-Austin Austin Texas 78757 —
South Texas Research Institute Brownsville Texas 78520 —
South Texas Research Institute Edinburg Texas 78539 —
LinQ Research, LLC Pearland Texas 77584 —
Pinnacle Clinical Research-San Antonio San Antonio Texas 78229 —
Bon Secours Liver Institute of Hampton Roads Newport News Virginia 23602 —
GI Select Health Research, LLC Richmond Virginia 23236 —
Velocity Clinical Spokane Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05402371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05402371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →